Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESSO 44 | Biological mesh in abdominal wall reconstruction during cytoreductive surgery: outcomes & advantages

Marc Pocard • 17 Oct 2025
ESSO 44
General

Marc Pocard, MD, PhD, Hospital Lariboisière Department of Visceral Cancer and Endocrine Surgery, Paris, France, discusses the outcomes of using biological mesh for abdominal wall reconstruction during cytoreductive surgery in patients with carcinomatosis. Prof. Pocard highlights that the use of biological mesh allows for a simpler and less time-consuming surgical procedure, with minimal complications, and notes that the mesh progressively disappears over time, typically within two years, without causing significant symptoms or issues for the patient. This interview took place at the 44th Congress of the European Society of Surgical Oncology (ESSO 44) in Gothenburg, Sweden.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Marc Pocard

Implications of low ctDNA detectability in peritoneal metastases from colon cancer
4:15
Implications of low ctDNA detectability in peritoneal metastases from colon cancer
Marc Pocard • 17 Oct 2025
Limitations of CT scans in peritoneal carcinomatosis and the need for blood-based tests
1:11
Limitations of CT scans in peritoneal carcinomatosis and the need for blood-based tests
Marc Pocard • 17 Oct 2025
Prophylactic CRS and HIPEC in appendiceal adenocarcinoma after perforated appendicitis
4:08
Prophylactic CRS and HIPEC in appendiceal adenocarcinoma after perforated appendicitis
Marc Pocard • 17 Oct 2025

Related Videos

Quality gaps in online patient information about AI in cancer care
1:24
Quality gaps in online patient information about AI in cancer care
Eleonora Teplinsky • 31 May 2026
Educating patients on AI risks and misinformation in cancer care
1:36
Educating patients on AI risks and misinformation in cancer care
Eleonora Teplinsky • 31 May 2026
Educational impact of a guideline-based hematology-oncology bootcamp curriculum
2:41
Educational impact of a guideline-based hematology-oncology bootcamp curriculum
Chinmay Jani • 31 May 2026
Reduced-dose radiation achieves local control in ATM-mutated cancers: Phase II results
1:26
Reduced-dose radiation achieves local control in ATM-mutated cancers: Phase II results
Amy Xu • 31 May 2026
The content of VJOncology is intended for healthcare professionals